Analyst firms · J.P. Morgan · BLUE

J.P. Morgan BLUE price target and rating history

bluebird bio Inc. (BLUE) · Health Care

J.P. Morgan rates bluebird bio Inc. (BLUE) Underweight with a $7 price target, as of its latest action on Nov 15, 2024. It has published 3 rating actions on BLUE since April 2023, including 0 upgrades and 2 downgrades.

Current rating
Underweight
Price target
$7
Median target, all firms
Too few
Actions on BLUE
3

Every J.P. Morgan rating on BLUE

Questions about J.P. Morgan and BLUE

What is J.P. Morgan's price target for BLUE?
J.P. Morgan's latest stated price target for bluebird bio Inc. (BLUE) is $7, from its action on Apr 28, 2023.
What is J.P. Morgan's rating on BLUE?
J.P. Morgan rates BLUE Underweight, a bearish rating, as of Nov 15, 2024.
When did J.P. Morgan last change its view on BLUE?
On Nov 15, 2024, J.P. Morgan downgrades to Underweight from Neutral.

More BLUE rating histories

All J.P. Morgan ratingsBLUE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.